BioVie Inc., a Nevada corporation, announced the filing of a PRE 14A preliminary proxy statement with the SEC, detailing the upcoming virtual Annual Meeting of Stockholders scheduled for November 7, 2024. The meeting will address the election of six directors, the ratification of EisnerAmper LLP as the independent registered public accounting firm for the 2025 fiscal year, an advisory vote on executive compensation, and the approval of an amendment to the 2019 Omnibus Equity Incentive Plan. The Board of Directors has recommended voting in favor of all proposals. Stockholders of record as of September 30, 2024, are entitled to participate and vote at the meeting, which will be conducted online due to the inability to attend in person. The proxy materials, including the 2024 Annual Report and Proxy Statement, will be available on BioVie's website and mailed to stockholders around October 9, 2024.

BioVie Inc., a Nevada corporation, announced the filing of a PRE 14A preliminary proxy statement with the SEC, detailing the upcoming virtual Annual Meeting of Stockholders scheduled for November 7, 2024. The meeting will address the election of six directors, the ratification of EisnerAmper LLP as the independent registered public accounting firm for the 2025 fiscal year, an advisory vote on executive compensation, and the approval of an amendment to the 2019 Omnibus Equity Incentive Plan. The Board of Directors has recommended voting in favor of all proposals. Stockholders of record as of September 30, 2024, are entitled to participate and vote at the meeting, which will be conducted online due to the inability to attend in person. The proxy materials, including the 2024 Annual Report and Proxy Statement, will be available on BioVie's website and mailed to stockholders around October 9, 2024.